A SPAC (Special Purpose Acquisition Company) is an alternative way of raising capital through an initial public offering (IPO), before acquiring an operating target company. SPAC management teams usually target a broader industry or sector rather than a specific company. Once the SPAC goes public, it has a set timeframe – typically 24 months – to use the funds that it has raised to acquire a target. If it does not make an acquisition (“de-SPAC”), it will return its funds to the investors.

SPAC activity has undergone a significant uptick recently. A SPAC not only poses an attractive opportunity for investors, it also offers companies greater control over their valuation and share price – unlike a traditional IPO with its inherent market volatility risks.

Houthoff's ECM team was the first in the Netherlands to assist with the launch of a Dutch SPAC, using an anti-takeover construction (European Healthcare Acquisition & Growth BV).
  • Advised European Healthcare Acquisition & Growth Company B.V., a Euronext Amsterdam-listed special purpose acquisition company (SPAC), on entering into a business combination with Croma-Pharma GmbH.

  • Advised Frazier Lifesciences Acquisition Corporation (SPAC), together with Goodwin Procter LLP, on its intended business combination with NewAmsterdam Pharma and listing of the combined entity on Nasdaq.
  • Advised De Agostini on the EUR 7.2 billion business combination of Pegasus Entrepreneurs with FL Entertainment. Awarded Best ECM Deal 2022 by M&A Community
  • Advised GP Bullhound Acquisition I SE (SPAC) on its IPO raising EUR 200 million.
  • Advised European Healthcare Acquisition & Growth Company B.V. (EHC), the first operators-led healthcare-focused acquisition and growth company in Europe, on successfully completing its EUR 200 million private placement and listing on Euronext Amsterdam.
  • Advised Ally Bridge Group on PIPE investment in EUR1.5 billion de-SPAC.
  • Advised Kensington Capital Acquisition Corp. II, a NYSE-listed special purpose acquisition company, on the merger agreement with Wallbox and Wallbox's listing as a Dutch N.V. on NYSE through the merger.
  • Advised, together with Goodwin Procter LLP, Qell Acquisition Corp., a publicly listed special purpose acquisition company (Nasdaq: QELL) in connection with the listing of Lilium as a Dutch N.V. on Nasdaq through a business combination with Qell.

主要联系人

阿姆斯特丹
Advocaat | Partner
+31 20 605 65 18
+31 6 5339 7433

主要联系人

阿姆斯特丹
Advocaat | Partner | Member of the Executive Committee
+31 20 605 61 10
+31 6 5165 9263
Paul de Vries

主要联系人

阿姆斯特丹
Notaris | Partner
+31 20 605 61 87
+31 6 4155 7508

主要联系人

鹿特丹
Advocaat | Partner
+31 10 217 29 55
+31 6 1884 8770